Clinical Trial: Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146880) titled 'Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome' on Aug. 21.

Brief Summary: The goal of this clinical trial is to learn if Empagliflozin works to treat Brugada syndrome patients by affecting their electrocardiographic (ECG) patterns, and to evaluate its safety.

The main questions it aims to answer are:

* Does Empagliflozin improve specific electrocardiogram (ECG) patterns in Brugada syndrome patients, specifically by observing the change in J-point elevation recorded in V1 and V2 leads at the 4th, 3rd, and 2nd intercostal spaces (ICSs)? A responder is defined as a decrease in J-point elevation ...